Business Wire

PVH/TOMMY-HILFIGER

13.2.2020 21:59:11 CET | Business Wire | Press release

Share
Tommy Hilfiger Celebrates a More Inclusive Fashion Landscape at Second Edition of Tommy Hilfiger Fashion Frontier Challenge

Tommy Hilfiger, which is owned by PVH Corp. [NYSE: PVH], announces Apon Wellbeing and A Beautiful Mess as winners of the 2019 Tommy Hilfiger Fashion Frontier Challenge . More than 400 applications were received for the second edition of the global program, which aims to support entrepreneurial start-up and scale-up stage businesses developing solutions that promote inclusive and positive change in fashion.

This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20200213005895/en/

“At Tommy Hilfiger, we’re committed to wasting nothing and welcoming all. From start to finish, I have been inspired by this talented group of social entrepreneurs whose innovations are making the fashion landscape more sustainable and inclusive,” said Tommy Hilfiger. “I am proud to congratulate this year’s winners, Apon Wellbeing and A Beautiful Mess. This is just the beginning for these start-ups and we will continue to mentor and foster these entrepreneurs who are so committed to making a positive impact in our industry.”

“The winners of the second Tommy Hilfiger Fashion Frontier Challenge represent the future of the fashion industry,” said Daniel Grieder, CEO, Tommy Hilfiger Global and PVH Europe. “As our industry continues to rapidly evolve, it is important to collaborate, both within and outside of the fashion landscape, and bring forward innovations that have the ability to transform our businesses for the better. Congratulations to all of the winners and finalists!”

Apon Wellbeing was awarded €75,000. The Bangladesh-based scale-up opens fair-priced shops carrying daily necessities inside factories, with products offered at a 10% discount to external prices and a points scheme that workers collect for free health-insurance and health services.

“When you are upcoming in the fashion value chain, endorsement from a brand like TOMMY HILFIGER immeasurably helps start-ups and scale-ups grow and increase impact,” said Saif Rashid, Apon Wellbeing Founder and Managing Director. “But the most important thing is the strategic support and mentorship the Tommy Hilfiger Fashion Frontier Challenge offers. The support TOMMY HILFIGER has given has already shaped our business model, strategy, communication and how we think about the future.”

Dutch start-up, A Beautiful Mess, was also awarded €75,000. A Beautiful Mess runs a creative space to assist refugees in realizing social and economic independence by creating sustainable apparel products.

“We need big players in the fashion industry to scale-up circular production initiatives, and that’s exactly what the Tommy Hilfiger Fashion Frontier Challenge offers,” said Naz Kawan, A Beautiful Mess Makerspace Director. “A collaborative, integrated approach is necessary if we want to transform the fashion industry’s supply chain. With the support of this global program, we are working towards a more circular, transparent and inclusive fashion landscape.”

The winners also received a year-long mentorship with Tommy Hilfiger’s and INSEAD’s global experts, as well as a place in the INSEAD Social Entrepreneurship Program (ISEP).

A third start-up, Sudara, was selected as the “Audience Favorite Vote” and was awarded €10,000. Based in India and the United States, Sudara is a scale-up pajama and loungewear company that develops professional and sewing skills in women who have escaped from or are at high risk of being sex trafficked.

“The Tommy Hilfiger Fashion Frontier Challenge is all about using fashion as a force for good, which directly speaks to our brand purpose,” said Shannon Keith, Sudara Inc. Founder and Chairwoman. “We’re particularly excited about winning the ‘Audience Favorite Vote,’ because it shows that what we’re doing really resonates with the teams at TOMMY HILFIGER, who are committed to making a difference in the fashion industry.”

Over a multi-step, multi-month process that began in May 2019, over 420 applicants were narrowed down to six finalists who were invited to develop and refine their business plans with the support of a dedicated team of social entrepreneur experts. During the program’s Final Event, which took place at Tommy Hilfiger’s Campus of the Future in Amsterdam, the Netherlands, on February 13, 2020, the six finalists pitched their concepts to a prestigious jury panel, including Mr. Tommy Hilfiger, Daniel Grieder, CEO, Tommy Hilfiger Global and PVH Europe, Noor Tagouri, Journalist, Activist and Speaker, Martijn Hagman, CFO, Tommy Hilfiger Global & COO, Tommy Hilfiger Global and PVH Europe, Willemijn Verloop, Founding Partner, Social Impact Venture, Steven Serneels, CEO and Board Member, EVPA, and Katrin Ley, Managing Director, Fashion for Good.

Tommy Hilfiger’s vision is to create fashion that wastes nothing and welcomes all. Find out more about the brand’s long-term sustainability efforts, particularly in the areas of inclusivity and circularity, at: https://global.tommy.com/en_int/about-us-corporate-sustainability .

Friends and followers of the brand are invited to join the conversation on social media using #TommyHilfiger and @TommyHilfiger.

About Tommy Hilfiger

With a brand portfolio that includes TOMMY HILFIGER and TOMMY JEANS , Tommy Hilfiger is one of the world’s most recognized premium designer lifestyle groups. Its focus is designing and marketing high-quality men’s tailored clothing and sportswear, women’s collection apparel and sportswear, kidswear, denim collections, underwear (including robes, sleepwear and loungewear), footwear and accessories. Through select licensees, Tommy Hilfiger offers complementary lifestyle products such as eyewear, watches, fragrance, swimwear, socks, small leather goods, home goods and luggage. The TOMMY JEANS product line consists of jeanswear and footwear for men and women, accessories, and fragrance. Merchandise under the TOMMY HILFIGER and TOMMY JEANS brands is available to consumers worldwide through an extensive network of TOMMY HILFIGER and TOMMY JEANS retail stores, leading specialty and department stores, select online retailers, and at tommy .com.

About PVH Corp.

PVH sets the standard of style as one of the most admired fashion and lifestyle companies in the world. We power brands that drive fashion forward – for good. Our iconic portfolio includes TOMMY HILFIGER , CALVIN KLEIN , Van Heusen , IZOD , ARROW , Speedo *, Warners , Olga and Geoffrey Beene brands, as well as the digital-centric True & Co. intimates brand. We market a variety of goods under these and other nationally and internationally known owned and licensed brands. PVH has over 38,000 associates operating in over 40 countries and nearly $9.7 billion in annual revenues. That’s the power of PVH.

*The Speedo brand is licensed for North America and the Caribbean in perpetuity from Speedo International Limited.

About Business Wire

Business Wire
Business Wire
101 California Street, 20th Floor
CA 94111 San Francisco

http://businesswire.com

Subscribe to releases from Business Wire

Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.

Latest releases from Business Wire

Galderma Receives U.S. FDA Approval for Differin® Epiduo® Acne Gel Prescription-to-OTC Switch22.5.2026 18:25:00 CEST | Press release

A unique Prescription-to-OTC switch in acne care, this approval expands access to a dermatologist-trusted, prescription-strength treatment for millions of acne sufferers ages 12 years and older Backed by more than 15 years of real-world dermatologist use and a robust clinical research program, this milestone demonstrates the depth of science behind the Differin® and Epiduo® heritage Adapalene plus benzoyl peroxide (0.1/2.5%) was the first FDA-approved, stable, fixed- dose prescription acne treatment to combine of benzoyl peroxide with a retinoid, and is now available over-the-counter The formulation is engineered to target multiple causes of acne more effectively than either of its individual active ingredients alone Galderma (SIX: GALD), the pure-play dermatology category leader, today announced that the United States (U.S.) Food and Drug Administration (FDA) has approved Differin® Epiduo® Acne Gel (Adapalene 0.1% and Benzoyl Peroxide 2.5% Acne Treatment) for over-the-counter (OTC) us

Avanzanite Bioscience’s Partner Agios Announces PYRUKYND® (mitapivat) Approval in the European Union for Adults with Thalassaemia22.5.2026 16:18:00 CEST | Press release

Avanzanite will commercialise and distribute PYRUKYND in Europe under its exclusive agreement with Agios Avanzanite is committed to collaborating with local authorities in the EU to enable access to PYRUKYND for adult patients with thalassaemia Avanzanite Bioscience B.V., a rapidly growing commercial-stage European specialty pharmaceutical company focused on rare diseases, today reported that its partner, Agios Pharmaceuticals, Inc. (Nasdaq: AGIO), a commercial-stage biopharmaceutical company headquartered in Cambridge, Massachusetts focused on delivering innovative medicines for patients with rare diseases, announced that the European Commission has granted marketing authorisation for PYRUKYND® (mitapivat), an oral pyruvate kinase (PK) activator, in adults for the treatment of anaemia associated with transfusion-dependent and non-transfusion-dependent alpha- or beta-thalassaemia, with an orphan medicinal product designation. This press release features multimedia. View the full releas

ICE Brent and ICE WTI Perpetual Futures to Launch on OKX22.5.2026 14:30:00 CEST | Press release

OKX, a blockchain technology and trading company serving more than 120 million customers globally,and Intercontinental Exchange (NYSE: ICE), one of the world's leading providers of financial market technology and data powering global capital markets including the New York Stock Exchange, today announced plans for OKX to launch perpetual futures based on ICE's Brent Crude and WTI Crude energy benchmarks. The products are expected to be available to trade on OKX’s platform in jurisdictions where OKX is licensed to offer perpetual futures products. The new OKX contracts represent a major step forward in expanding regulated access to global commodity markets through digital asset infrastructure. This first product collaboration between OKX and ICE comes after the companies established a strategic relationship in March 2026. ICE operates some of the world’s leading exchanges, clearing houses and market data services across energy, commodities, fixed income and equities markets. ICE’s future

Enhertu® Recommended for Approval in the EU by CHMP for Patients with Previously Treated HER2 Positive Metastatic Solid Tumors22.5.2026 14:00:00 CEST | Press release

Enhertu® (trastuzumab deruxtecan) has been recommended for approval in the European Union (EU) as a monotherapy for the treatment of adult patients with unresectable or metastatic HER2 positive (immunohistochemistry [IHC] 3+) solid tumors who have received prior treatment and who have no satisfactory treatment options. Enhertu is a specifically engineered HER2 directed DXd antibody drug conjugate (ADC) discovered by Daiichi Sankyo (TSE: 4568) and being jointly developed and commercialized by Daiichi Sankyo and AstraZeneca (LSE/STO/NYSE: AZN). The Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) based its positive opinion on results from patients with HER2 positive (IHC 3+) tumors in three phase 2 trials including DESTINY-PanTumor02,DESTINY-Lung01 andDESTINY-CRC02 where Enhertu demonstrated clinically meaningful responses across a broad range of tumors. The recommendation will now be reviewed by the European Commission, which has the authority

Future Health Challenge Awards USD 300,000 to Early Detection and Population Health Sensing Tools on Sidelines of World Health Assembly22.5.2026 13:45:00 CEST | Press release

Global teams recognised in the Future Health Challenge for solutions designed to detect health risks earlier and support faster health system decisions Future Health – A Global Initiative by Abu Dhabi and MIT Solve announce the winners of the inaugural Future Health ChallengeWinning solution equips frontline health workers in low-resource settings with mobile clinical decision-support tools, enabling earlier detection and more effective care deliveryTeams competed for a USD 200,000 grand prize and two USD 50,000 runner-up awards on the sidelines of the 79th World Health Assembly in GenevaWinners recognised for solutions advancing anticipatory, data-driven health systems Three global teams developing early detection and real-time population health monitoring solutions have secured a total of USD 300,000 on the sidelines of the 79th World Health Assembly. The winning solutions address critical challenges in early detection, continuous population insight and more timely decision making, s

In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.

Visit our pressroom
World GlobeA line styled icon from Orion Icon Library.HiddenA line styled icon from Orion Icon Library.Eye